GlassScriptPhysician profile
April Archer
NPI 1194058826
$661.72
in general payments reported to CMS, 2019-2025
9 companies · $67.42 in 2025
The $67.42 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $88.73 · 2023: $270 · 2024: $108 · 2025: $67.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $192.93 | 2023-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $143.46 | 2021-2025 | Bexsero, Rotarix, Pediarix |
| Tris Pharma INC | $104.65 | 2021-2023 | Quillivant, Quillichew Er, Dyanavel Xr |
| Pfizer INC. | $96.66 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $47.18 | 2022-2024 | |
| Cranial Technologies, INC | $29.83 | 2025 | Doc Band |
| Corium, LLC | $18.65 | 2023 | Azstarys |
| Sanofi Pasteur INC. | $15.02 | 2023 | |
| Neos Therapeutics, LP | $13.34 | 2023 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.